In het fase-3-programma (SURPASS) resulteerde tirzepatide namelijk in indrukwekkende effecten in T2DM-patinten
Abbasinejad, MD , evaluates each patients medical history, current weight, previous weight loss efforts, medications, lifestyle, and overall health goals before determining whether Contrave may be appropriate
Preclinical studies have demonstrated no significant toxicity even at doses far exceeding therapeutic ranges
That lower cost can make treatment more accessible for adults without insurance coverage for weight loss medication
For example, menopause benefits are increasingly common, with 15% of employers offering or planning to offer them next year, up from just 4% a year ago
Gain a clinical perspective on the impact of glp-1 agonists on joint pain and inflammation to understand how these treatments serve as a foundation for long-term musculoskeletal health